首页> 外文期刊>Nanomedicine >Nanotechnological strategies for therapeutic targeting of tumor vasculature
【24h】

Nanotechnological strategies for therapeutic targeting of tumor vasculature

机译:靶向治疗肿瘤血管的纳米技术策略

获取原文
获取原文并翻译 | 示例
           

摘要

Neovascularization plays fundamental roles in tumor growth and metastasis. Tumor blood vessels are highly accessible and express various angiogenic markers that are either not present or are expressed at low levels in normal vessels, thereby serving as favorable targets for cancer therapy. Cancer nanotechnology, as an integrated platform, offers great opportunities for optimizing drug efficacy and pharmacokinetics while reducing side effects. Nanoparticles with tunable size, shape and surface modification have been exploited to achieve effective tumor vascular targeting. Here, we briefly introduce the signatures of tumor neovascularization and the review investigations on vascular-targeted anti-tumor nanomedicines. We also provide our perspectives on the promising fields of combination therapy and theranostic nanomedicines, as well as the challenges of nanotechnology-based cancer therapy. Furthermore, introducing new functionality would significantly consolidate the current development of nanomaterials based on tumor vasculature targeting.
机译:新血管形成在肿瘤生长和转移中起基本作用。肿瘤血管是高度可及的并且表达各种在正常血管中不存在或以低水平表达的血管生成标记,从而成为癌症治疗的有利靶标。癌症纳米技术作为一个集成平台,为优化药物功效和药代动力学同时减少副作用提供了巨大的机会。具有可调节的大小,形状和表面修饰的纳米颗粒已被开发来实现有效的肿瘤血管靶向。在这里,我们简要介绍肿瘤新血管形成的特征以及针对血管靶向的抗肿瘤纳米药物的综述研究。我们还提供了有关联合疗法和治疗性纳米药物前景广阔的领域的观点,以及基于纳米技术的癌症疗法的挑战。此外,引入新功能将大大巩固基于肿瘤脉管系统靶向的纳米材料的当前发展。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号